Susquehanna International Group, LLP Novavax Inc Put Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$10.71 - $17.11 $1.89 Million - $3.02 Million	-176,600 Reduced 12.05%	1,288,900 $16.3 Million
Q2 2024 Aug 15, 2024	BUY	$3.89 - $20.97 $2.16 Million - $11.6 Million	554,500 Added 60.87%	1,465,500 $18.6 Million
Q1 2024 May 07, 2024	SELL	$3.76 - $6.02 $1.74 Million - $2.79 Million	-462,800 Reduced 33.69%	911,000 $4.35 Million
Q4 2023 Feb 14, 2024	SELL	$4.8 - $7.67 $3.78 Million - $6.03 Million	-786,600 Reduced 36.41%	1,373,800 $6.59 Million
Q3 2023 Nov 14, 2023	BUY	$6.81 - $9.74 $1.05 Million - $1.5 Million	153,700 Added 7.66%	2,160,400 $15.6 Million
Q2 2023 Aug 11, 2023	BUY	$6.67 - $9.52 $4.06 Million - $5.79 Million	608,400 Added 43.51%	2,006,700 $14.9 Million
Q1 2023 May 16, 2023	SELL	$5.76 - $12.48 $4.75 Million - $10.3 Million	-824,900 Reduced 37.1%	1,398,300 $9.69 Million
Q4 2022 Feb 14, 2023	BUY	$8.86 - $25.04 $11.6 Million - $32.9 Million	1,312,800 Added 144.2%	2,223,200 $22.9 Million
Q3 2022 Nov 14, 2022	SELL	$18.2 - $76.12 $10.4 Million - $43.4 Million	-570,600 Reduced 38.53%	910,400 $16.6 Million

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $629M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.